![TNIH key visual](https://marketing.webassets.siemens-healthineers.com/88502f492b0a40c9/068330586c02/v/1bc7bced8f39/siemens-healthineers-ld-tnih-content-page-16-9.jpg)
High-Sensitivity Troponin I Assay
Fast, Accurate, Actionable Results When it Matters Most
Proven, True High-Sensitivity Troponin I Assays
Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks.
Siemens Healthineers offers proven, true high-sensitivity cardiac troponin I assays:
- Demonstrate clinical proof that the Siemens Healthineers’ assays are true high-sensitivity troponin I assays according to current guidelines.1-4
- Offer fast, accurate, and actionable results to leverage current protocols
- Provide confidence in results due to minimal assay interferences, including biotin*
Essa informação foi útil?
Apple F., Sandoval Y., Jaffe A., and Ordonez-Llanos J. Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their
Impact on Clinical Care. Report of the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Clinical Chemistry 63:01 (2016)
Alan H.B. Wu, Clinical Chemistry 64:4 645–655 (2018)
European Heart Journal 2020 00, 179 ESC GUIDELINESdoi:10.1093/eurheartj/ehaa575
European Heart Journal 2020 00, 179 ESC GUIDELINESdoi:10.1093/eurheartj/ehaa575
Nowak, et al. Outpatient Versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute
Myocardial Infarction: Findings from the HIGH-US Study. American Heart Journal 2020 Oct 27. DOI: 10.1016/j.ahj.2020.10.067
*Atellica IM TnIH & ADVIA Centaur TNIH assays: Biotin interference demonstrating less than 10% change in results up to 3500 ng/mL.
Product availability may vary from country to country and is subject to local regulatory requirements.